Biophysics in drug discovery: impact, challenges and opportunities
Crossref DOI link: https://doi.org/10.1038/nrd.2016.123
Published Online: 2016-08-12
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Renaud, Jean-Paul
Chung, Chun-wa
Danielson, U. Helena
Egner, Ursula
Hennig, Michael
Hubbard, Roderick E.
Nar, Herbert
Text and Data Mining valid from 2016-08-12
Article History
First Online: 12 August 2016
Competing interests
: J.P.R. is a co-founder and a shareholder of NovAliX.